Table 1.
gene | gene alteration | disease/disorder | references |
---|---|---|---|
transferases | |||
PARP9 | overexpression | B-aggressive lymphoma | [11,12] |
breast cancer | [13] | ||
PARP14 | overexpression | B-aggressive lymphoma | [11,14] |
sarcoma | [15] | ||
asthma | [16] | ||
hepatocellular carcinoma | [17] | ||
PARP15 | overexpression | B-aggressive lymphoma | [11] |
readers/erasers | |||
ALC1 (CHD1L) | overexpression | hepatocellular carcinoma | [18] |
breast cancer | [19] | ||
colorectal carcinoma | [20] | ||
ARH1 | missense mutations | lung, breast and colon cancers | [21] |
ARH3 | truncations/mutations | neurodegenerative diseases | [22,23] |
GDAP2 (MacroD3) | point mutations | ataxia, progressive spasticity and dementia | [24] |
MacroD1 | overexpression | endometrial carcinoma | [25] |
gastric carcinoma | [26] | ||
colorectal carcinoma | [27,28] | ||
breast carcinoma | [29,30] | ||
MacroD2 | single-nucleotide polymorphisms | autism | [31–33] |
microdeletion Int 5 | kabuki syndrome | [34,35] | |
locus deletions | various cancers | [36,37] | |
deletions, missense mutations | colorectal cancer | [38] | |
TARG1 | premature stop codon | neurodegeneration | [39] |